Onderneming Travere Therapeutics, Inc.
Aandelen
TVTX
US89422G1076
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,26 USD | +1,62% | +19,01% | -30,37% |
Vakgebied
Aantal werknemers: 380
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Tiopronin Products
77,1
%
| 98 | 48,9 % | 98 | 77,1 % | +0,37% |
FILSPARI
22,9
%
| - | - | 29 | 22,9 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 201 | 100,0 % | 128 | 100,0 % | -36,40% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Dube
CEO | Chief Executive Officer | 51 | 04-01-19 |
Chris Cline
DFI | Director of Finance/CFO | 40 | 01-08-14 |
Jula Inrig
CTO | Chief Tech/Sci/R&D Officer | 49 | 04-01-22 |
Bill Rote
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-02-17 |
Naomi Eichenbaum
IRC | Investor Relations Contact | - | - |
Human Resources Officer | - | - | |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 01-12-14 |
Peter Heerma
PRN | Corporate Officer/Principal | 53 | 01-10-19 |
Casey H. Logan
PRN | Corporate Officer/Principal | 52 | 05-03-18 |
Elizabeth Reed
LAW | General Counsel | 53 | 04-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Coughlin
BRD | Director/Board Member | 57 | 31-03-15 |
Jeffrey Meckler
BRD | Director/Board Member | 57 | 08-10-14 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 08-04-20 |
Gary Lyons
CHM | Chairman | 73 | 09-10-14 |
Roy Baynes
BRD | Director/Board Member | 69 | 01-07-16 |
John Orwin
BRD | Director/Board Member | 59 | 23-03-17 |
Ron Squarer
BRD | Director/Board Member | 57 | 12-04-17 |
Sandra E. Poole
BRD | Director/Board Member | 60 | 13-05-19 |
Eric Dube
CEO | Chief Executive Officer | 51 | 04-01-19 |
Sandra Calvin
AUD | Comptroller/Controller/Auditor | 59 | 01-12-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 76 108 829 | 75 201 296 ( 98,81 %) | 0 | 98,81 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,37% | 476 mln. | |
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+6,79% | 14,16 mld. | |
+38,61% | 12,63 mld. |
- Beurs
- Aandelen
- Koers TVTX
- Onderneming Travere Therapeutics, Inc.